Año: 2019
Journal Impact Factor (JIF): 10.2520
Categoría | Edición | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|---|
IMMUNOLOGY | SCIE | 10/159 | Q1 | T1 | D1 |
ONCOLOGY | SCIE | 16/244 | Q1 | T1 | D1 |
Año: 2019
Journal Citation Indicator (JCI): 2,040
Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
---|---|---|---|---|---|
IMMUNOLOGY | 11/176 | Q1 | T1 | D1 | 94,03 |
ONCOLOGY | 19/308 | Q1 | T1 | D1 | 93,99 |
Año:
2019
CiteScore:
8,600
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Pharmacology | 21/301 | Q1 | T1 | D1 |
Cancer Research | 33/198 | Q1 | T1 | D2 |
Immunology | 32/200 | Q1 | T1 | D2 |
Immunology and Allergy | 27/180 | Q1 | T1 | D2 |
Molecular Medicine | 20/165 | Q1 | T1 | D2 |
Oncology | 40/331 | Q1 | T1 | D2 |
SJR año:
2019
Factor de Impacto:
4,194
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Cancer Research | 11/241 | Q1 | T1 | D1 |
Immunology | 14/245 | Q1 | T1 | D1 |
Immunology and Allergy | 11/230 | Q1 | T1 | D1 |
Molecular Medicine | 7/185 | Q1 | T1 | D1 |
Oncology | 13/419 | Q1 | T1 | D1 |
Pharmacology | 6/349 | Q1 | T1 | D1 |
Agencia | Código de Proyecto |
---|---|
OmniSeq, Inc. (Buffalo, NY) | - |
# | Autor | Afiliación |
---|---|---|
1 | Conroy, Jeffrey M. | Roswell Park Cancer Institute; OmniSeq Inc. (United States) |
2 | Pabla, Sarabjot | OmniSeq Inc. (United States) |
3 | Nesline, Mary K. | OmniSeq Inc. (United States) |
4 | Glenn, Sean T. | Roswell Park Cancer Institute; OmniSeq Inc. (United States) |
5 | Papanicolau-Sengos, Antonios | OmniSeq Inc. (United States) |
6 | Burgher, Blake | OmniSeq Inc. (United States) |
7 | Andreas, Jonathan | OmniSeq Inc. (United States) |
8 | Giamo, Vincent | OmniSeq Inc. (United States) |
9 | Wang, Yirong | OmniSeq Inc. (United States) |
10 | Lenzo, Felicia L. | OmniSeq Inc. (United States) |
11 | Bshara, Wiam | Roswell Park Cancer Institute (United States) |
12 | Khalil, Maya | Roswell Park Cancer Institute (United States) |
13 | Dy, Grace K. | Roswell Park Cancer Institute (United States) |
14 | Madden, Katherine G. | Dartmouth-Hitchcock Medical Center (United States) |
15 | Shirai, Keisuke | Dartmouth-Hitchcock Medical Center (United States) |
16 | Dragnev, Konstantin | Dartmouth-Hitchcock Medical Center (United States) |
17 | Tafe, Laura J. | Dartmouth-Hitchcock Medical Center (United States) |
18 | Zhu, Jason | Duke University Medical Center (United States) |
19 | Labriola, Matthew | Duke University Medical Center (United States) |
20 | Marin, Daniele | Duke University Medical Center (United States) |
21 | McCall, Shannon J. | Duke University Medical Center (United States) |
22 | Clarke, Jeffrey | Duke University Medical Center (United States) |
23 | George, Daniel J. | Duke University Medical Center (United States) |
24 | Zhang, Tian | Duke University Medical Center (United States) |
25 | Zibelman, Matthew | Fox Chase Cancer Center (United States) |
26 | Ghatalia, Pooja | Fox Chase Cancer Center (United States) |
27 | Araujo-Fernandez, Isabel | Hospital Universitario Virgen Macarena (Spain) |
28 | De La Cruz-Merino, Luis | Hospital Universitario Virgen Macarena (Spain) |
29 | Singavi, Arun | Medical College of Wisconsin (United States) |
30 | George, Ben | Medical College of Wisconsin (United States) |
31 | MacKinnon, Alexander C. | Medical College of Wisconsin (United States) |
32 | Thompson, Jonathan | Medical College of Wisconsin (United States) |
33 | Singh, Rajbir | Meharry Medical College (United States) |
34 | Jacob, Robin | Meharry Medical College (United States) |
35 | Kasuganti, Deepa | Community Hospital (United States) |
36 | Shah, Neel | Community Hospital (United States) |
37 | Day, Roger | University of Pittsburgh (United States) |
38 | Galluzzi, Lorenzo | Université de Paris; Weill Cornell Medicine (United States) |
39 | Gardner, Mark | OmniSeq Inc. (United States) |
40 | Roswell Park Cancer Institute; OmniSeq Inc. (United States) |